APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Quetiapine Fumarate Sustained Release Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Quetiapine Fumarate Sustained Release Tablets Industry Growth and Trends Forecast to 2032

Report ID 174030310128 December 2025104 pages

Choose your research edition.

Industry ResearchQuetiapine Fumarate Sustained Release Tablets Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Quetiapine Fumarate Sustained Release Tablets Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Quetiapine Fumarate Sustained Release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Quetiapine Fumarate Sustained Release Tablets Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Quetiapine Fumarate Sustained Release Tablets Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

According to APO Research, the global Quetiapine Fumarate Sustained Release Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Quetiapine Fumarate Sustained Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Quetiapine Fumarate Sustained Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Quetiapine Fumarate Sustained Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Quetiapine Fumarate Sustained Release Tablets market include Dr. Reddy's Laboratories, Lupin Limited, Luye Pharma Limited, PHARMATHEN INVESTMENTS GROUP LIMITED, Seroquel, Torrent Pharmaceuticals, Mylan N.V., Sandoz and Sun Pharmaceutical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Quetiapine Fumarate Sustained Release Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Quetiapine Fumarate Sustained Release Tablets market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Quetiapine Fumarate Sustained Release Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Quetiapine Fumarate Sustained Release Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Quetiapine Fumarate Sustained Release Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Quetiapine Fumarate Sustained Release Tablets Market by Company

Dr. Reddy's Laboratories

Lupin Limited

Luye Pharma Limited

PHARMATHEN INVESTMENTS GROUP LIMITED

Seroquel

Torrent Pharmaceuticals

Mylan N.V.

Sandoz

Sun Pharmaceutical Industries

Teva Pharmaceutical Industries

Quetiapine Fumarate Sustained Release Tablets Segment by Type

50mg

200mg

300mg

400mg

Quetiapine Fumarate Sustained Release Tablets Segment by Application

Hospital

Clinic

Others

Quetiapine Fumarate Sustained Release Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quetiapine Fumarate Sustained Release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Quetiapine Fumarate Sustained Release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quetiapine Fumarate Sustained Release Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Quetiapine Fumarate Sustained Release Tablets companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Quetiapine Fumarate Sustained Release Tablets Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Region (2021-2026) Table 4. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Region (2027-2032) Table 6. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Quetiapine Fumarate Sustained Release Tablets Market Size Share by Type (2021-2026) Table 9. Global Quetiapine Fumarate Sustained Release Tablets Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Quetiapine Fumarate Sustained Release Tablets Market Size Share Forecasted by Type (2027-2032) Table 11. North America Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Quetiapine Fumarate Sustained Release Tablets Market Size Share by Application (2021-2026) Table 24. Global Quetiapine Fumarate Sustained Release Tablets Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Quetiapine Fumarate Sustained Release Tablets Market Size Share Forecasted by Application (2027-2032) Table 26. North America Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Quetiapine Fumarate Sustained Release Tablets Industry Trends Table 37. Quetiapine Fumarate Sustained Release Tablets Industry Drivers Table 38. Quetiapine Fumarate Sustained Release Tablets Industry Opportunities and Challenges Table 39. Quetiapine Fumarate Sustained Release Tablets Industry Restraints Table 40. Global Quetiapine Fumarate Sustained Release Tablets Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Company (2021-2026) Table 42. Global Quetiapine Fumarate Sustained Release Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Quetiapine Fumarate Sustained Release Tablets Key Company Headquarters & Area Served Table 44. Global Quetiapine Fumarate Sustained Release Tablets Company, Product Type & Application Table 45. Global Quetiapine Fumarate Sustained Release Tablets Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Quetiapine Fumarate Sustained Release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Dr. Reddy's Laboratories Company Information Table 49. Dr. Reddy's Laboratories Business Overview Table 50. Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Product Portfolio Table 52. Dr. Reddy's Laboratories Recent Development Table 53. Lupin Limited Company Information Table 54. Lupin Limited Business Overview Table 55. Lupin Limited Quetiapine Fumarate Sustained Release Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Lupin Limited Quetiapine Fumarate Sustained Release Tablets Product Portfolio Table 57. Lupin Limited Recent Development Table 58. Luye Pharma Limited Company Information Table 59. Luye Pharma Limited Business Overview Table 60. Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Product Portfolio Table 62. Luye Pharma Limited Recent Development Table 63. PHARMATHEN INVESTMENTS GROUP LIMITED Company Information Table 64. PHARMATHEN INVESTMENTS GROUP LIMITED Business Overview Table 65. PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Product Portfolio Table 67. PHARMATHEN INVESTMENTS GROUP LIMITED Recent Development Table 68. Seroquel Company Information Table 69. Seroquel Business Overview Table 70. Seroquel Quetiapine Fumarate Sustained Release Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Seroquel Quetiapine Fumarate Sustained Release Tablets Product Portfolio Table 72. Seroquel Recent Development Table 73. Torrent Pharmaceuticals Company Information Table 74. Torrent Pharmaceuticals Business Overview Table 75. Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Product Portfolio Table 77. Torrent Pharmaceuticals Recent Development Table 78. Mylan N.V. Company Information Table 79. Mylan N.V. Business Overview Table 80. Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Product Portfolio Table 82. Mylan N.V. Recent Development Table 83. Sandoz Company Information Table 84. Sandoz Business Overview Table 85. Sandoz Quetiapine Fumarate Sustained Release Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Sandoz Quetiapine Fumarate Sustained Release Tablets Product Portfolio Table 87. Sandoz Recent Development Table 88. Sun Pharmaceutical Industries Company Information Table 89. Sun Pharmaceutical Industries Business Overview Table 90. Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product Portfolio Table 92. Sun Pharmaceutical Industries Recent Development Table 93. Teva Pharmaceutical Industries Company Information Table 94. Teva Pharmaceutical Industries Business Overview Table 95. Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product Portfolio Table 97. Teva Pharmaceutical Industries Recent Development Table 98. North America Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021-2026) Table 101. North America Quetiapine Fumarate Sustained Release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Quetiapine Fumarate Sustained Release Tablets Market Share Forecast by Country (2027-2032) Table 103. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021-2026) Table 106. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Quetiapine Fumarate Sustained Release Tablets Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021-2026) Table 111. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Share Forecast by Country (2027-2032) Table 113. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021-2026) Table 116. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America Quetiapine Fumarate Sustained Release Tablets Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021-2026) Table 121. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Quetiapine Fumarate Sustained Release Tablets Product Image Figure 3. Global Quetiapine Fumarate Sustained Release Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Quetiapine Fumarate Sustained Release Tablets Market Size (2021-2032) & (US$ Million) Figure 5. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Region: 2025 VS 2032 Figure 6. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Region (2021-2032) Figure 7. North America Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. 50mg Image Figure 13. Global 50mg Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. 200mg Image Figure 15. Global 200mg Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. 300mg Image Figure 17. Global 300mg Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. 400mg Image Figure 19. Global 400mg Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Quetiapine Fumarate Sustained Release Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Type 2025 VS 2032 Figure 22. North America Quetiapine Fumarate Sustained Release Tablets Market Size Share by Type (2021-2032) Figure 23. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size Share by Type (2021-2032) Figure 25. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Quetiapine Fumarate Sustained Release Tablets Market Size Share by Type (2021-2032) Figure 27. Hospital Image Figure 28. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Clinic Image Figure 30. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Quetiapine Fumarate Sustained Release Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Application 2025 VS 2032 Figure 35. North America Quetiapine Fumarate Sustained Release Tablets Market Size Share by Application (2021-2032) Figure 36. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size Share by Application (2021-2032) Figure 38. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Quetiapine Fumarate Sustained Release Tablets Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Quetiapine Fumarate Sustained Release Tablets Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Quetiapine Fumarate Sustained Release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021-2032) Figure 45. Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Quetiapine Fumarate Sustained Release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021-2032) Figure 48. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021-2032) Figure 51. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Quetiapine Fumarate Sustained Release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021-2032) Figure 54. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 200mg
  • 300mg
  • 400mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Dr. Reddy's Laboratories
  • Lupin Limited
  • Luye Pharma Limited
  • PHARMATHEN INVESTMENTS GROUP LIMITED
  • Seroquel
  • Torrent Pharmaceuticals
  • Mylan N.V.
  • Sandoz
  • Sun Pharmaceutical Industries
  • Teva Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Quetiapine Fumarate Sustained Release Tablets Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2021-2032)
  5. 1.4.1 Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2021-2026)
  6. 1.4.2 Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2027-2032)
  7. 1.5 Key Regions Quetiapine Fumarate Sustained Release Tablets Market Size (2021-2032)
  8. 1.5.1 North America Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (2021-2032)
2 Quetiapine Fumarate Sustained Release Tablets Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 50mg
  3. 2.1.2 200mg
  4. 2.1.3 300mg
  5. 2.1.4 400mg
  6. 2.2 Global Quetiapine Fumarate Sustained Release Tablets Market Size by Type
  7. 2.2.1 Global Quetiapine Fumarate Sustained Release Tablets Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Quetiapine Fumarate Sustained Release Tablets Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Quetiapine Fumarate Sustained Release Tablets Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Quetiapine Fumarate Sustained Release Tablets Market Size by Regions
  11. 2.3.1 North America Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Type (2021-2026)
3 Quetiapine Fumarate Sustained Release Tablets Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Others
  5. 3.2 Global Quetiapine Fumarate Sustained Release Tablets Market Size by Application
  6. 3.2.1 Global Quetiapine Fumarate Sustained Release Tablets Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Quetiapine Fumarate Sustained Release Tablets Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Quetiapine Fumarate Sustained Release Tablets Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Quetiapine Fumarate Sustained Release Tablets Market Size by Regions
  10. 3.3.1 North America Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Quetiapine Fumarate Sustained Release Tablets Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Quetiapine Fumarate Sustained Release Tablets Industry Trends
  2. 4.2 Quetiapine Fumarate Sustained Release Tablets Industry Drivers
  3. 4.3 Quetiapine Fumarate Sustained Release Tablets Industry Opportunities and Challenges
  4. 4.4 Quetiapine Fumarate Sustained Release Tablets Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Quetiapine Fumarate Sustained Release Tablets Revenue (2021-2026)
  2. 5.2 Global Quetiapine Fumarate Sustained Release Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Quetiapine Fumarate Sustained Release Tablets Key Company Headquarters & Area Served
  4. 5.4 Global Quetiapine Fumarate Sustained Release Tablets Company, Product Type & Application
  5. 5.5 Global Quetiapine Fumarate Sustained Release Tablets Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Quetiapine Fumarate Sustained Release Tablets Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Quetiapine Fumarate Sustained Release Tablets Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Quetiapine Fumarate Sustained Release Tablets Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Dr. Reddy's Laboratories
  2. 6.1.1 Dr. Reddy's Laboratories Company Information
  3. 6.1.2 Dr. Reddy's Laboratories Business Overview
  4. 6.1.3 Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Product Portfolio
  6. 6.1.5 Dr. Reddy's Laboratories Recent Developments
  7. 6.2 Lupin Limited
  8. 6.2.1 Lupin Limited Company Information
  9. 6.2.2 Lupin Limited Business Overview
  10. 6.2.3 Lupin Limited Quetiapine Fumarate Sustained Release Tablets Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Lupin Limited Quetiapine Fumarate Sustained Release Tablets Product Portfolio
  12. 6.2.5 Lupin Limited Recent Developments
  13. 6.3 Luye Pharma Limited
  14. 6.3.1 Luye Pharma Limited Company Information
  15. 6.3.2 Luye Pharma Limited Business Overview
  16. 6.3.3 Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Product Portfolio
  18. 6.3.5 Luye Pharma Limited Recent Developments
  19. 6.4 PHARMATHEN INVESTMENTS GROUP LIMITED
  20. 6.4.1 PHARMATHEN INVESTMENTS GROUP LIMITED Company Information
  21. 6.4.2 PHARMATHEN INVESTMENTS GROUP LIMITED Business Overview
  22. 6.4.3 PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Product Portfolio
  24. 6.4.5 PHARMATHEN INVESTMENTS GROUP LIMITED Recent Developments
  25. 6.5 Seroquel
  26. 6.5.1 Seroquel Company Information
  27. 6.5.2 Seroquel Business Overview
  28. 6.5.3 Seroquel Quetiapine Fumarate Sustained Release Tablets Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Seroquel Quetiapine Fumarate Sustained Release Tablets Product Portfolio
  30. 6.5.5 Seroquel Recent Developments
  31. 6.6 Torrent Pharmaceuticals
  32. 6.6.1 Torrent Pharmaceuticals Company Information
  33. 6.6.2 Torrent Pharmaceuticals Business Overview
  34. 6.6.3 Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Product Portfolio
  36. 6.6.5 Torrent Pharmaceuticals Recent Developments
  37. 6.7 Mylan N.V.
  38. 6.7.1 Mylan N.V. Company Information
  39. 6.7.2 Mylan N.V. Business Overview
  40. 6.7.3 Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Product Portfolio
  42. 6.7.5 Mylan N.V. Recent Developments
  43. 6.8 Sandoz
  44. 6.8.1 Sandoz Company Information
  45. 6.8.2 Sandoz Business Overview
  46. 6.8.3 Sandoz Quetiapine Fumarate Sustained Release Tablets Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Sandoz Quetiapine Fumarate Sustained Release Tablets Product Portfolio
  48. 6.8.5 Sandoz Recent Developments
  49. 6.9 Sun Pharmaceutical Industries
  50. 6.9.1 Sun Pharmaceutical Industries Company Information
  51. 6.9.2 Sun Pharmaceutical Industries Business Overview
  52. 6.9.3 Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product Portfolio
  54. 6.9.5 Sun Pharmaceutical Industries Recent Developments
  55. 6.10 Teva Pharmaceutical Industries
  56. 6.10.1 Teva Pharmaceutical Industries Company Information
  57. 6.10.2 Teva Pharmaceutical Industries Business Overview
  58. 6.10.3 Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product Portfolio
  60. 6.10.5 Teva Pharmaceutical Industries Recent Developments
7 North America
  1. 7.1 North America Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021-2026)
  3. 7.3 North America Quetiapine Fumarate Sustained Release Tablets Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021-2026)
  3. 8.3 Europe Quetiapine Fumarate Sustained Release Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021-2026)
  3. 10.3 South America Quetiapine Fumarate Sustained Release Tablets Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst